SOURCE: Ogilvy CommonHealth Worldwide

Ogilvy CommonHealth Worldwide

May 20, 2016 11:38 ET

Ogilvy CommonHealth Worldwide's Ritesh Patel to Deliver Keynote Presentation at AAFA's asthma & allergy friendly(C) Certification Program council meeting

PARSIPPANY, NJ--(Marketwired - May 20, 2016) -  Ogilvy CommonHealth Worldwide (, the health behavior change specialists of Ogilvy & Mather (, and a WPP company (NASDAQ: WPPGY) (, today announced Ritesh Patel, EVP, chief digital officer, has been invited to serve as the keynote speaker to kick off the Asthma and Allergy Foundation of America's (AAFA) asthma & allergy friendly© Certification Program council meeting on May 24 at the Embassy of Ireland in Washington, DC.

Mr. Patel, a member of the AAFA's board of directors, will discuss how consumers are increasingly using digital outlets and social media platforms to help make informed decisions about the treatment of allergy and asthma symptoms. The two-day AAFA asthma & allergy friendly© Certification Program council meeting will give attendees the opportunity to learn more about the scientifically-validated, asthma and allergy friendly products available to those living with these disorders.

To learn more about the AAFA asthma & allergy friendly© Certification Program council meeting, please reach out to Alex Burgess --

About Ogilvy CommonHealth Worldwide
Ogilvy CommonHealth Worldwide is committed to creativity and effectiveness in healthcare communications, everywhere. Our global headquarters are in Parsippany, NJ, with additional hubs in New York, London, Paris and Singapore. We maintain multiple additional offices in markets critical to our clients' global aspirations. Ogilvy CommonHealth Worldwide provides marketing services including behavioral insights, content strategy and management, digital, interactive and new media services, marketing analytics and research, media planning and buying, medical education, payer marketing and market access, professional advertising and promotion, public affairs and relations, relationship marketing, sales training development, social media and social listening, and wellness and consumer advertising and promotion. The network also offers scientific communications and publications planning services through a wholly owned separate legal entity. The organization houses and maintains individual Ogilvy CommonHealth and Ogilvy Healthworld brand identities within the marketplace.

About the asthma & allergy friendly™ Certification Program
The Asthma and Allergy Foundation of America (AAFA) is the leading national nonprofit organization fighting asthma and allergic diseases. AAFA provides free information, conducts educational programs, fights for patients' rights and funds research to find better treatments and cures. The asthma & allergy friendly™ Certification Program is jointly run by AAFA and Allergy Standards Limited (ASL), a physician-led global certification company that prepares independent standards for testing a wide range of products to determine their suitability for asthma and allergy patients. The Certification Program is an independent laboratory-based product-testing program that helps families with asthma and allergies find more suitable products for their homes. Visit to see the full catalog of Certified products and get a free guide on how to reduce allergens and irritants in your home.

About AAFA
Founded in 1953 and celebrating over 60 years of service, the Asthma and Allergy Foundation of America (AAFA) is the oldest and largest nonprofit patient organization dedicated to improving the quality of life for people with asthma, allergies and related conditions through education, advocacy and research. AAFA provides practical information, community-based services, support and referrals through a national network of chapters and educational support groups. Through its Kids With Food Allergies division, AAFA offers the oldest, most exclusive online support community for families raising children with food allergies at In addition, AAFA sponsors and advocates for research to advance the basic science relevant to treatment and cure. It also champions translational research so that the science that we have is applied more consistently and reliably. For more information, visit

Contact Information

  • Contact:
    Beth Paulino
    Kerianne Slattery
    Ogilvy CommonHealth Worldwide
    973.352.1000 tel